Effect on joint health of routine prophylaxis with Bayer’s sucrose-formulated recombinant factor VIII (rFVIII-FS) in adolescents and adults previously treated on demand: MRI analyses from the 3-Year Spinart study

• Lundin B
• Hong W
• Raunig D
• Engelen S
• Peterfy C
• Werk
• Manco-Johnson MJ